Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) FCF Margin (2018)

Historic FCF Margin for DiaMedica Therapeutics (DMAC) over the last 1 years, with Q3 2018 value amounting to 371.8%.

  • DiaMedica Therapeutics' FCF Margin changed N/A to 371.8% in Q3 2018 from the same period last year, while for Jun 2019 it was 1950.2%, marking a year-over-year change of. This contributed to the annual value of 65073.53% for FY2024, which is 201628300.0% down from last year.
  • As of Q3 2018, DiaMedica Therapeutics' FCF Margin stood at 371.8%.
  • DiaMedica Therapeutics' FCF Margin's 5-year high stood at 371.8% during Q3 2018, with a 5-year trough of 371.8% in Q3 2018.